chr9-133071468-G-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001807.6(CEL):​c.1966G>C​(p.Ala656Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A656A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., cov: 6)
Exomes 𝑓: 0.0042 ( 18 hom. )
Failed GnomAD Quality Control

Consequence

CEL
NM_001807.6 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 1.01

Publications

6 publications found
Variant links:
Genes affected
CEL (HGNC:1848): (carboxyl ester lipase) The protein encoded by this gene is a glycoprotein secreted from the pancreas into the digestive tract and from the lactating mammary gland into human milk. The physiological role of this protein is in cholesterol and lipid-soluble vitamin ester hydrolysis and absorption. This encoded protein promotes large chylomicron production in the intestine. Also its presence in plasma suggests its interactions with cholesterol and oxidized lipoproteins to modulate the progression of atherosclerosis. In pancreatic tumoral cells, this encoded protein is thought to be sequestrated within the Golgi compartment and is probably not secreted. This gene contains a variable number of tandem repeat (VNTR) polymorphism in the coding region that may influence the function of the encoded protein. [provided by RefSeq, Jul 2008]
CEL Gene-Disease associations (from GenCC):
  • maturity-onset diabetes of the young type 8
    Inheritance: AD, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014160126).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00174 (84/48336) while in subpopulation SAS AF = 0.00493 (8/1622). AF 95% confidence interval is 0.00245. There are 0 homozygotes in GnomAd4. There are 36 alleles in the male GnomAd4 subpopulation. Median coverage is 6. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 84 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CELNM_001807.6 linkc.1966G>C p.Ala656Pro missense_variant Exon 11 of 11 ENST00000372080.8 NP_001798.3 B4DSX9Q86SR3O75612

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CELENST00000372080.8 linkc.1966G>C p.Ala656Pro missense_variant Exon 11 of 11 5 NM_001807.6 ENSP00000361151.6 P19835-1

Frequencies

GnomAD3 genomes
AF:
0.00174
AC:
84
AN:
48350
Hom.:
0
Cov.:
6
show subpopulations
Gnomad AFR
AF:
0.000196
Gnomad AMI
AF:
0.00556
Gnomad AMR
AF:
0.00123
Gnomad ASJ
AF:
0.00948
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00488
Gnomad FIN
AF:
0.00181
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00247
Gnomad OTH
AF:
0.00154
GnomAD2 exomes
AF:
0.000644
AC:
2
AN:
3104
AF XY:
0.000482
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00156
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00415
AC:
473
AN:
113892
Hom.:
18
Cov.:
5
AF XY:
0.00476
AC XY:
297
AN XY:
62406
show subpopulations
African (AFR)
AF:
0.000835
AC:
2
AN:
2396
American (AMR)
AF:
0.00128
AC:
2
AN:
1566
Ashkenazi Jewish (ASJ)
AF:
0.00696
AC:
13
AN:
1868
East Asian (EAS)
AF:
0.000349
AC:
2
AN:
5726
South Asian (SAS)
AF:
0.0165
AC:
160
AN:
9692
European-Finnish (FIN)
AF:
0.00533
AC:
35
AN:
6568
Middle Eastern (MID)
AF:
0.00714
AC:
3
AN:
420
European-Non Finnish (NFE)
AF:
0.00292
AC:
234
AN:
80110
Other (OTH)
AF:
0.00397
AC:
22
AN:
5546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.551
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00174
AC:
84
AN:
48336
Hom.:
0
Cov.:
6
AF XY:
0.00157
AC XY:
36
AN XY:
22976
show subpopulations
African (AFR)
AF:
0.000196
AC:
3
AN:
15340
American (AMR)
AF:
0.00123
AC:
6
AN:
4884
Ashkenazi Jewish (ASJ)
AF:
0.00948
AC:
11
AN:
1160
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2100
South Asian (SAS)
AF:
0.00493
AC:
8
AN:
1622
European-Finnish (FIN)
AF:
0.00181
AC:
3
AN:
1660
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
82
European-Non Finnish (NFE)
AF:
0.00247
AC:
51
AN:
20662
Other (OTH)
AF:
0.00155
AC:
1
AN:
646
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.439
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3
Nov 19, 2018
Center for Personalized Medicine, Children's Hospital Los Angeles
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 24, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Maturity onset diabetes mellitus in young Uncertain:1
Apr 25, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.014
T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.84
T
M_CAP
Uncertain
0.26
D
MetaRNN
Benign
0.014
T
MetaSVM
Benign
-0.75
T
PhyloP100
1.0
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
0.060
N
REVEL
Benign
0.17
Sift
Uncertain
0.010
D
Sift4G
Uncertain
0.014
D
Vest4
0.22
MVP
0.56
MPC
0.98
ClinPred
0.099
T
GERP RS
0.65
gMVP
0.046
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587780309; hg19: chr9-135946855; COSMIC: COSV104658896; API